Nextsteprobo
Baltimore, US · Maryland corporation · 1 known investors
NextStep Robotics develops AMBLE, a wearable robotic device for foot drop rehabilitation in stroke survivors and other neurological conditions. The device combines robotics and algorithms to provide graded assistance for gait retraining in clinical rehabilitation settings.
HealthtechMedical DevicesRobotics
Founders & leadership
BH
Bradley HennessieExecutive Officer, Director, Promoter
AR
Anindo RoyExecutive Officer, Director, Promoter
RM
Richard MackoExecutive Officer, Director
LF
Larry ForresterExecutive Officer, Director
BF
BRENDA FURLOWDirector
ES
ERIKA SMITHDirector
MD
MAGGIE DENGDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$1MraisedApr 2026 · 5 investors · Other TechnologyRule 506(b)
▶$1MraisedApr 2026 · 5 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- BRADLEY HENNESSIEExecutive Officer, Director, Promoter
- ANINDO ROYExecutive Officer, Director, Promoter
- ERIKA SMITHDirector
- BRENDA FURLOWDirector
- MAGGIE DENGDirector
- Offering amount
- $3M
- Amount sold
- $1M
- Minimum investment
- $100K
- First sale
- Nov 2025
- Incorporated
- Corporation, Maryland
- Federal exemptions
- 06b
▶$400KraisedJan 2024 · 1 investors · Other TechnologyRule 506(b)
▶$400KraisedJan 2024 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- BRENDA FURLOWDirector
- ERIKA SMITHDirector
- ANINDO ROYExecutive Officer, Director, Promoter
- MAGGIE DENGDirector
- BRADLEY HENNESSIEExecutive Officer, Director, Promoter
- Offering amount
- $1.5M
- Amount sold
- $400K
- First sale
- Dec 2023
- Incorporated
- Corporation, Maryland
- Federal exemptions
- 06b
▶$450KraisedDec 2019 · 4 investors · Other Health CareRule 506(b)
▶$450KraisedDec 2019 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Elizabeth GoodDirector
- Anindo RoyExecutive Officer, Director
- Richard MackoExecutive Officer, Director
- Larry ForresterExecutive Officer, Director
- Bradley HennessieExecutive Officer, Director
- Offering amount
- $450K
- Amount sold
- $450K
- Minimum investment
- $50K
- First sale
- Dec 2018
- Incorporated
- Corporation, Maryland, 2017
- Federal exemptions
- 06b
▶$750KraisedFeb 2018 · 4 investors · Other Health CareRule 506(b)
▶$750KraisedFeb 2018 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Richard MackoExecutive Officer, Director
- Bradley HennessieExecutive Officer, Director
- Anindo RoyExecutive Officer, Director
- Larry ForresterExecutive Officer, Director
- Offering amount
- $750K
- Amount sold
- $750K
- Minimum investment
- $50K
- First sale
- Jan 2018
- Incorporated
- Corporation, Maryland, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $1.1M |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.